Literature DB >> 8435078

Effect of thiol compounds on human complement component C4.

S Edmonds1, A Gibb, E Sim.   

Abstract

Thiol compounds have been investigated as inhibitors of the covalent binding reaction of human complement protein C4 using Sepharose-C1s as a combined activating and binding surface. o- and p-substituted aminothiophenols are equally effective inhibitors, whereas the m-substituted compound is a less potent inhibitor. The anti-hypertensive drug captopril is also shown to inhibit the covalent binding reaction. A comparison of the effects of these compounds on the covalent binding reaction of isolated C4A and C4B has been made. Results suggest that a Pro-to-Leu substitution in C4B is likely to account for the differences in inhibitory potency of C4B compared with C4A observed with the aromatic inhibitors.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8435078      PMCID: PMC1132247          DOI: 10.1042/bj2890801

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  25 in total

1.  Structural differences between the two human complement C4 isotypes affect the humoral immune response.

Authors:  O Finco; S Li; M Cuccia; F S Rosen; M C Carroll
Journal:  J Exp Med       Date:  1992-02-01       Impact factor: 14.307

2.  Oral contraceptives and gallbladder disease. Royal College of General Practitioners' oral contraception study.

Authors: 
Journal:  Lancet       Date:  1982-10-30       Impact factor: 79.321

3.  [Lupus erythematosus due to penicillamine associated with Wilson's disease].

Authors:  G Boudin; B Pépin; P Godeau; J C Vernant; H Gouerou
Journal:  Ann Med Interne (Paris)       Date:  1971-02

4.  Silver stain for proteins in polyacrylamide gels: a modified procedure with enhanced uniform sensitivity.

Authors:  J H Morrissey
Journal:  Anal Biochem       Date:  1981-11-01       Impact factor: 3.365

5.  Captopril: five years on.

Authors:  G P Hodsman; J I Robertson
Journal:  Br Med J (Clin Res Ed)       Date:  1983-09-24

6.  Purification of human C3b inactivator by monoclonal-antibody affinity chromatography.

Authors:  L Hsiung; A N Barclay; M R Brandon; E Sim; R R Porter
Journal:  Biochem J       Date:  1982-04-01       Impact factor: 3.857

7.  The covalent-binding reaction of complement component C3.

Authors:  R B Sim; T M Twose; D S Paterson; E Sim
Journal:  Biochem J       Date:  1981-01-01       Impact factor: 3.857

8.  Effect of penicillamine on complement in vitro and in vivo.

Authors:  O J Mellbye; E Munthe
Journal:  Ann Rheum Dis       Date:  1977-10       Impact factor: 19.103

9.  The molecular basis for the difference in immune hemolysis activity of the Chido and Rodgers isotypes of human complement component C4.

Authors:  D E Isenman; J R Young
Journal:  J Immunol       Date:  1984-06       Impact factor: 5.422

10.  A molecular basis for the two locus model of human complement component C4.

Authors:  M H Roos; E Mollenhauer; P Démant; C Rittner
Journal:  Nature       Date:  1982-08-26       Impact factor: 49.962

View more
  1 in total

1.  Investigating the selectivity of metalloenzyme inhibitors.

Authors:  Joshua A Day; Seth M Cohen
Journal:  J Med Chem       Date:  2013-10-14       Impact factor: 7.446

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.